Eating Disorders Trial, Recruiting NCT07435974 Sponsor: Universidad Catolica de Temuco Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT07435974
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older.
  • You consider yourself to be overweight or obese (based on your own report).
  • You have had at least 3 episodes of binge eating in the past 30 days, and these episodes cause you significant emotional distress.
  • You have a long-term health condition linked to being overweight (such as an underactive or overactive thyroid, high cholesterol, high blood pressure, type 2 diabetes, or polycystic ovary syndrome), as long as it is currently well-managed and stable.
  • If you have a stable long-term health condition, it must have been managed with the same treatment for at least 12 weeks, with no recent medication changes, no recent serious health events, and at least one related medical check-up in the past 12 months.
  • If you take any psychiatric medications, your dosage and type must have stayed the same for at least 12 weeks before joining.
  • You have daily access to the internet and a computer or smartphone that allows you to take part in online sessions and complete assessments.

Who may not be able to join:

  • You have engaged in behaviors to "undo" binge eating — such as making yourself vomit or regularly using laxatives — in the past 60 days.
  • You are currently pregnant or breastfeeding.
  • You have previously had weight-loss (bariatric) surgery.
  • You are currently having thoughts of suicide.
  • You currently have symptoms of a serious mental health condition — such as psychosis, bipolar disorder, complex PTSD, or a severe personality disorder — that significantly affects your daily functioning or requires specialist mental health care.
  • You currently have a substance use problem serious enough that it requires specialist clinical treatment.
  • You are currently receiving psychological therapy or nutritional treatment on a regular basis, or have an active treatment plan in place.
  • You have a health condition that is not well-controlled, not being monitored by a doctor, or has recently involved medication changes, in a way that could affect your eating behavior, mood, or ability to take part (confirm with trial site).
  • You have significant difficulties in daily functioning that, in the research team's judgment, would prevent you from safely and consistently taking part in the program (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Neli Escandon, PhD, Universidad Catolica de Temuco

Phone: +56452685078

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad Catolica de Temuco
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
30 July 2026

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Proportion of Eligible Participants Who Initiate the COR Intervention; Proportion of Participants Who Complete All Eight COR Intervention Sessions; Proportion of Participants Who Attend the 1-Month Follow-Up Session After Completing the COR Intervention; Proportion of Participants Who Discontinue the COR Intervention Before Completing All Eight Sessions; Proportion of Scheduled Assessment Instruments Completed by Participants; Acceptability of the COR Protocol Among Participants and Interventionists; Implementation Fidelity of the COR Protocol

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov